Amarin Corp Plcuk (AMRN) Consolidated Net Income (2010 - 2026)

Amarin Corp Plcuk (AMRN) reported Consolidated Net Income of -$10.5 million for Q1 2026, up 33.03% year-over-year from -$7.9 million in Q1 2025, and down 758.82% quarter-over-quarter from -$1.2 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Consolidated Net Income (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 17 years of Consolidated Net Income data on file, last reported at -$10.5 million in Q1 2026.

  • Consolidated Net Income for Q1 2026 came in at -$10.5 million, up 33.03% year-over-year; the trailing twelve-month figure through Mar 2026 was -$33.6 million (down 109.94% YoY), and the FY2025 annual result was -$38.8 million, down 277.89% from the prior year.
  • Consolidated Net Income eased to -$10.5 million in Q1 2026 per AMRN's latest filing, from -$1.2 million in the prior quarter.
  • Over five years, Consolidated Net Income peaked at $110.0 million in Q4 2022 and troughed at -$70.0 million in Q2 2022.
  • A 5-year average of -$6.8 million and a median of -$10.5 million in 2026 frame the typical range for Consolidated Net Income.
  • On a YoY basis, Consolidated Net Income climbed as much as 648.53% in 2022 and fell as far as 1841.14% in 2022.
  • A 5-year view of Consolidated Net Income shows it stood at $110.0 million in 2022, then sank by 105.25% to -$5.8 million in 2023, then soared by 503.01% to $23.3 million in 2024, then slumped by 105.25% to -$1.2 million in 2025, then sank by 758.82% to -$10.5 million in 2026.
  • Business Quant data shows AMRN's Consolidated Net Income at -$10.5 million in Q1 2026, -$1.2 million in Q4 2025, and -$7.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 3.30 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 7.40 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 5.24 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 697.00 Mn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn -4.21 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 1.82 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 2.02 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn -13.00 Mn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 2.68 Bn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn -10.51 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -10.51 Mn
Dec 31, 2025 -1.22 Mn
Sep 30, 2025 -7.74 Mn
Jun 30, 2025 -14.14 Mn
Mar 31, 2025 -15.70 Mn
Dec 31, 2024 23.30 Mn
Sep 30, 2024 -25.13 Mn
Jun 30, 2024 1.52 Mn
Mar 31, 2024 -9.95 Mn
Dec 31, 2023 -5.78 Mn
Sep 30, 2023 -19.31 Mn
Jun 30, 2023 -17.56 Mn
Mar 31, 2023 -16.46 Mn
Dec 31, 2022 110.02 Mn
Sep 30, 2022 -5.14 Mn
Jun 30, 2022 -69.96 Mn
Mar 31, 2022 -31.56 Mn
Dec 31, 2021 14.70 Mn
Sep 30, 2021 -13.15 Mn
Jun 30, 2021 7.81 Mn